| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
18,027 |
12,886 |
$1.60M |
| 99051 |
|
12 |
12 |
$172.56 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,622 |
2,864 |
$25.27 |
| 82962 |
|
1,311 |
980 |
$0.00 |
| 90680 |
|
178 |
172 |
$0.00 |
| 90697 |
|
202 |
195 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,324 |
7,709 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
555 |
515 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
234 |
172 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,040 |
765 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
214 |
167 |
$0.00 |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
76 |
51 |
$0.00 |
| 90474 |
|
178 |
172 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
111 |
92 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
213 |
157 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
40 |
26 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,289 |
1,745 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
415 |
358 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
577 |
523 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,136 |
445 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
741 |
518 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
336 |
315 |
$0.00 |
| 81025 |
|
1,473 |
931 |
$0.00 |
| 81003 |
|
1,336 |
933 |
$0.00 |
| 90670 |
|
159 |
151 |
$0.00 |
| 90710 |
|
29 |
25 |
$0.00 |
| 90671 |
|
104 |
104 |
$0.00 |
| 81002 |
|
15 |
13 |
$0.00 |
| 90633 |
|
35 |
30 |
$0.00 |
| 99173 |
|
24 |
14 |
$0.00 |
| 92552 |
|
28 |
20 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
44 |
37 |
$0.00 |